Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Carretta

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|July 27, 2014
Ex vivo assays to study self-renewal, long-term expansion, and leukemic transformation of genetically modified human hematopoietic and patient-derived leukemic stem cellsPallavi Sontakke, Marco Carretta, Marta Capala, et al.
Traffic (Copenhagen, Denmark)|November 21, 2014
Intrinsically disordered linker and plasma membrane-binding motif sort Ist2 and Ssy1 to junctionsAnnemarie Kralt, Marco Carretta, Muriel Mari, et al.
Haematologica|March 26, 2026
MLL-AF9 expression levels do not instruct lineage fateEmmanouil Kyrloglou, Marco Carretta, Annet Brouwers-Vos, et al.
Plos One|December 15, 2017
BRD3/4 inhibition and FLT3-ligand deprivation target pathways that are essential for the survival of human MLL-AF9+ leukemic cellsMarco Carretta, Annet Z Brouwers-Vos, Matthieu Bosman, et al.
Matrix Biology Plus|February 24, 2022
Uncovering mediators of collagen degradation in the tumor microenvironmentMarie-Louise Thorseth, Marco Carretta, Christina Jensen, et al.
Oncogene|January 12, 2022
Blockade of beta-adrenergic receptors reduces cancer growth and enhances the response to anti-CTLA4 therapy by modulating the tumor microenvironmentKlaire Yixin Fjæstad, Anne Mette Askehøj Rømer, Victor Goitea, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 26, 2020
Collagen Density Modulates the Immunosuppressive Functions of MacrophagesAnne Mette H Larsen, Dorota E Kuczek, Adrija Kalvisa, et al.
Experimental Hematology|May 1, 2017
Genetically engineered mesenchymal stromal cells produce IL-3 and TPO to further improve human scaffold-based xenograft modelsMarco Carretta, Bauke de Boer, Jenny Jaques, et al.
Pharmaceutics|May 28, 2022
Chitooligosaccharides Improve the Efficacy of Checkpoint Inhibitors in a Mouse Model of Lung CancerAstrid Zedlitz Johansen, Marco Carretta, Marie-Louise Thorseth, et al.
Oncoimmunology|September 14, 2020
The metabolic enzyme arginase-2 is a potential target for novel immune modulatory vaccinesStine Emilie Weis-Banke, Mie Linder Hübbe, Morten Orebo Holmström, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|July 27, 2014
Ex vivo assays to study self-renewal, long-term expansion, and leukemic transformation of genetically modified human hematopoietic and patient-derived leukemic stem cellsPallavi Sontakke, Marco Carretta, Marta Capala, et al.
Traffic (Copenhagen, Denmark)|November 21, 2014
Intrinsically disordered linker and plasma membrane-binding motif sort Ist2 and Ssy1 to junctionsAnnemarie Kralt, Marco Carretta, Muriel Mari, et al.
Haematologica|March 26, 2026
MLL-AF9 expression levels do not instruct lineage fateEmmanouil Kyrloglou, Marco Carretta, Annet Brouwers-Vos, et al.
Plos One|December 15, 2017
BRD3/4 inhibition and FLT3-ligand deprivation target pathways that are essential for the survival of human MLL-AF9+ leukemic cellsMarco Carretta, Annet Z Brouwers-Vos, Matthieu Bosman, et al.
Matrix Biology Plus|February 24, 2022
Uncovering mediators of collagen degradation in the tumor microenvironmentMarie-Louise Thorseth, Marco Carretta, Christina Jensen, et al.
Oncogene|January 12, 2022
Blockade of beta-adrenergic receptors reduces cancer growth and enhances the response to anti-CTLA4 therapy by modulating the tumor microenvironmentKlaire Yixin Fjæstad, Anne Mette Askehøj Rømer, Victor Goitea, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 26, 2020
Collagen Density Modulates the Immunosuppressive Functions of MacrophagesAnne Mette H Larsen, Dorota E Kuczek, Adrija Kalvisa, et al.
Experimental Hematology|May 1, 2017
Genetically engineered mesenchymal stromal cells produce IL-3 and TPO to further improve human scaffold-based xenograft modelsMarco Carretta, Bauke de Boer, Jenny Jaques, et al.
Pharmaceutics|May 28, 2022
Chitooligosaccharides Improve the Efficacy of Checkpoint Inhibitors in a Mouse Model of Lung CancerAstrid Zedlitz Johansen, Marco Carretta, Marie-Louise Thorseth, et al.
Oncoimmunology|September 14, 2020
The metabolic enzyme arginase-2 is a potential target for novel immune modulatory vaccinesStine Emilie Weis-Banke, Mie Linder Hübbe, Morten Orebo Holmström, et al.
Pageof 2